Aurobindo Pharma | ARBP - Operating Expenses

Stock Price
1,409.85
Daily Change
-11.45 -0.81%
Monthly
8.18%
Yearly
16.55%
Q2 Forecast
1,382.70

Aurobindo Pharma reported INR73.37B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Cipla INR 60.98B 1.06B Dec/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Hindustan Unilever INR 129.9B 1.2B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 106.63B 780M Dec/2025